salicylic acid has been researched along with cysteinyldopa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| d'Ischia, M; Memoli, S; Napolitano, A; Nappi, AJ; Prota, G | 1 |
| Hidano, A; Jin, KM; Kawashima, M; Nogita, T; Toyoda, H | 1 |
2 other study(ies) available for salicylic acid and cysteinyldopa
| Article | Year |
|---|---|
5-S-cysteinyldopa, a diffusible product of melanocyte activity, is an efficient inhibitor of hydroxylation/oxidation reactions induced by the Fenton system.
Topics: Aerobiosis; Anaerobiosis; Borohydrides; Chelating Agents; Cysteinyldopa; Dihydroxyphenylalanine; Edetic Acid; Free Radical Scavengers; Hydrogen Peroxide; Hydroxylation; Iron Chelating Agents; Melanocytes; Oxidation-Reduction; Salicylates; Salicylic Acid | 1996 |
Pedunculated pigmented eccrine poroma of the scalp with increased urinary excretion of 5-S-cysteinyldopa.
Topics: Adenoma, Sweat Gland; Cysteinyldopa; Diagnosis, Differential; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Scalp; Skin Neoplasms; Solitary Pulmonary Nodule | 1990 |